Inhibition Effect ofCopper (Ⅱ) Theophylline Nanocomplex on Phosphodiesterase (PDE) Enzyme Activity in Human Serum of Iraqi Patients with Asthma Disease

Copper (Ⅱ) theophylline [Cu(THP)2(H2O)4] complex in nanoscale has synthesized by ultrasonic sonication method. This method was used in the development of smaller, dispersed, and unaggregated nanoparticles (NPs). The structure of nanocomplex was described and suggested by the molar conductance, Fouri...

Full description

Bibliographic Details
Main Authors: Zainab Sabri Abbas, Ahmad Hussein Ismail, Hassanain Kamil Al-Bairmani, Ahmed Mahdi Rheima, Ameer Radhi Sultan, Srwa Hashim Mohammed
Format: Article
Language:English
Published: Tsinghua University Press 2021-12-01
Series:Nano Biomedicine and Engineering
Subjects:
Online Access:https://www.sciopen.com/article/10.5101/nbe.v13i4.p364-371
_version_ 1797673375815958528
author Zainab Sabri Abbas
Ahmad Hussein Ismail
Hassanain Kamil Al-Bairmani
Ahmed Mahdi Rheima
Ameer Radhi Sultan
Srwa Hashim Mohammed
author_facet Zainab Sabri Abbas
Ahmad Hussein Ismail
Hassanain Kamil Al-Bairmani
Ahmed Mahdi Rheima
Ameer Radhi Sultan
Srwa Hashim Mohammed
author_sort Zainab Sabri Abbas
collection DOAJ
description Copper (Ⅱ) theophylline [Cu(THP)2(H2O)4] complex in nanoscale has synthesized by ultrasonic sonication method. This method was used in the development of smaller, dispersed, and unaggregated nanoparticles (NPs). The structure of nanocomplex was described and suggested by the molar conductance, Fourier transform infrared spectroscopy (FTIR), ultraviolet-visible spectroscopy (UV-Vis), solubility, atomic fire absorption, and C.H.N. elemental analysis as octahedral geometry. The size and morphology of nanocomplex measured by transmission electron microscopy (TEM) were 20 nm. The nanocomplex was studied on phosphodiesterase enzyme activity in human serum of Iraqi patient?s asthma disease. The results showed a highly significant (p < 0.01) increase in the serum levels of phosphodiesterase enzyme activity in asthma patients (mean = 14.939 ± 3.021 ng/mL) compared with a control group (mean = 9.974 ± 2.032 ng/mL). The result also showed a highly significant (p < 0.01) decrease in the serum levels of phosphodiesterase activity in patients of asthma disease with theophylline (mean = 11.253 ± 2.479 ng/mL) compared to serum patients without nano and control groups. It is vital that the result showed a highly significant (p < 0.01) decrease in the serum levels of phosphodiesterase activity in patients of asthma disease with copper nano complex (mean = 9.563 ± 2.082 ng/mL) compared in patients of asthma disease with and without theophylline. As for comparing asthma disease with copper nano complex and control group, the result showed there was no significant effect (p > 0.05).
first_indexed 2024-03-11T21:43:37Z
format Article
id doaj.art-624b90fcc1a141a19a73b4f0c9bad2f9
institution Directory Open Access Journal
issn 2150-5578
language English
last_indexed 2024-03-11T21:43:37Z
publishDate 2021-12-01
publisher Tsinghua University Press
record_format Article
series Nano Biomedicine and Engineering
spelling doaj.art-624b90fcc1a141a19a73b4f0c9bad2f92023-09-26T11:05:06ZengTsinghua University PressNano Biomedicine and Engineering2150-55782021-12-0113436437110.5101/nbe.v13i4.p364-371Inhibition Effect ofCopper (Ⅱ) Theophylline Nanocomplex on Phosphodiesterase (PDE) Enzyme Activity in Human Serum of Iraqi Patients with Asthma DiseaseZainab Sabri Abbas0Ahmad Hussein Ismail1Hassanain Kamil Al-Bairmani2Ahmed Mahdi Rheima3Ameer Radhi Sultan4Srwa Hashim Mohammed5Kut University College, Dentistry Department, Al-Kut, Wasit, Iraq, 52001Mustansiriyah University, College of Science, Department of Chemistry. IraqMustansiriyah University, College of Science, Department of Chemistry. IraqWasit University, College of Science, Department of Chemistry, Kut, IraqDepartment of Chemistry Lab, Al-lmamine Al-Kadhumain Medical City Hospital, Baghdad, IraqGarmian University, College of Education, Department of Chemistry. Kalar, IraqCopper (Ⅱ) theophylline [Cu(THP)2(H2O)4] complex in nanoscale has synthesized by ultrasonic sonication method. This method was used in the development of smaller, dispersed, and unaggregated nanoparticles (NPs). The structure of nanocomplex was described and suggested by the molar conductance, Fourier transform infrared spectroscopy (FTIR), ultraviolet-visible spectroscopy (UV-Vis), solubility, atomic fire absorption, and C.H.N. elemental analysis as octahedral geometry. The size and morphology of nanocomplex measured by transmission electron microscopy (TEM) were 20 nm. The nanocomplex was studied on phosphodiesterase enzyme activity in human serum of Iraqi patient?s asthma disease. The results showed a highly significant (p < 0.01) increase in the serum levels of phosphodiesterase enzyme activity in asthma patients (mean = 14.939 ± 3.021 ng/mL) compared with a control group (mean = 9.974 ± 2.032 ng/mL). The result also showed a highly significant (p < 0.01) decrease in the serum levels of phosphodiesterase activity in patients of asthma disease with theophylline (mean = 11.253 ± 2.479 ng/mL) compared to serum patients without nano and control groups. It is vital that the result showed a highly significant (p < 0.01) decrease in the serum levels of phosphodiesterase activity in patients of asthma disease with copper nano complex (mean = 9.563 ± 2.082 ng/mL) compared in patients of asthma disease with and without theophylline. As for comparing asthma disease with copper nano complex and control group, the result showed there was no significant effect (p > 0.05).https://www.sciopen.com/article/10.5101/nbe.v13i4.p364-371nanocomplexasthmaphosphodiesterase (pde)theophyllineultrasonic sonication method
spellingShingle Zainab Sabri Abbas
Ahmad Hussein Ismail
Hassanain Kamil Al-Bairmani
Ahmed Mahdi Rheima
Ameer Radhi Sultan
Srwa Hashim Mohammed
Inhibition Effect ofCopper (Ⅱ) Theophylline Nanocomplex on Phosphodiesterase (PDE) Enzyme Activity in Human Serum of Iraqi Patients with Asthma Disease
Nano Biomedicine and Engineering
nanocomplex
asthma
phosphodiesterase (pde)
theophylline
ultrasonic sonication method
title Inhibition Effect ofCopper (Ⅱ) Theophylline Nanocomplex on Phosphodiesterase (PDE) Enzyme Activity in Human Serum of Iraqi Patients with Asthma Disease
title_full Inhibition Effect ofCopper (Ⅱ) Theophylline Nanocomplex on Phosphodiesterase (PDE) Enzyme Activity in Human Serum of Iraqi Patients with Asthma Disease
title_fullStr Inhibition Effect ofCopper (Ⅱ) Theophylline Nanocomplex on Phosphodiesterase (PDE) Enzyme Activity in Human Serum of Iraqi Patients with Asthma Disease
title_full_unstemmed Inhibition Effect ofCopper (Ⅱ) Theophylline Nanocomplex on Phosphodiesterase (PDE) Enzyme Activity in Human Serum of Iraqi Patients with Asthma Disease
title_short Inhibition Effect ofCopper (Ⅱ) Theophylline Nanocomplex on Phosphodiesterase (PDE) Enzyme Activity in Human Serum of Iraqi Patients with Asthma Disease
title_sort inhibition effect ofcopper ii theophylline nanocomplex on phosphodiesterase pde enzyme activity in human serum of iraqi patients with asthma disease
topic nanocomplex
asthma
phosphodiesterase (pde)
theophylline
ultrasonic sonication method
url https://www.sciopen.com/article/10.5101/nbe.v13i4.p364-371
work_keys_str_mv AT zainabsabriabbas inhibitioneffectofcopperiitheophyllinenanocomplexonphosphodiesterasepdeenzymeactivityinhumanserumofiraqipatientswithasthmadisease
AT ahmadhusseinismail inhibitioneffectofcopperiitheophyllinenanocomplexonphosphodiesterasepdeenzymeactivityinhumanserumofiraqipatientswithasthmadisease
AT hassanainkamilalbairmani inhibitioneffectofcopperiitheophyllinenanocomplexonphosphodiesterasepdeenzymeactivityinhumanserumofiraqipatientswithasthmadisease
AT ahmedmahdirheima inhibitioneffectofcopperiitheophyllinenanocomplexonphosphodiesterasepdeenzymeactivityinhumanserumofiraqipatientswithasthmadisease
AT ameerradhisultan inhibitioneffectofcopperiitheophyllinenanocomplexonphosphodiesterasepdeenzymeactivityinhumanserumofiraqipatientswithasthmadisease
AT srwahashimmohammed inhibitioneffectofcopperiitheophyllinenanocomplexonphosphodiesterasepdeenzymeactivityinhumanserumofiraqipatientswithasthmadisease